Can-Fite Biopharma (CF5.STU) Q3 2026 Earnings

27AugConfirmed
Q1 2026
Next
-2.59
-1.72
-0.86
0

Details

Expected EPS
-0.142923
Actual EPS
N/A
Surprise EPS
0.14
Surprise Percent
+100%

Description

Can-Fite Biopharma (CF5.STU) will report earnings of for Q3 2026 on August 27, 2026.

0 Comments

Share your thoughts